Won Seog Kim

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 34

Top Topics

Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Annals of laboratory medicine

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Jinchul Kim, Jinhyun Cho, Moon Hee Lee, Sang Eun Yoon, Won Seog Kim, Seok Jin Kim
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis. Blood 144 (6) (2024)
Seok Jin Kim, Sang Eun Yoon, Won Seog Kim
Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies. Annals of laboratory medicine 44 (3) (2024)
Seok Jin Kim, Sang Eun Yoon, Won Seog Kim
Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies. Annals of laboratory medicine 44 (3) (2024)
Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra, Sung Rye Park, Michael Yevgeniy Tolstorukov, Sean M McCabe, Jessica Duffy, Abner Louissaint, Jani Huuhtanen, Dipabarna Bhattacharya, Mohamed El Missiry, Min Jung Koh, Foster Powers, Elizabeth A Morgan, Lei Yang, Brandy Pinckney, Matthew J Cotton, Andrew Crabbe, Jessica Beth Ziemba, Ian Brain, Tayla B Heavican-Foral, Javeed Iqbal, Ronald Nemec, Anna Baird Rider, Josie Germain Ford, Min Ji Koh, Nora Scanlan, Thomas P Loughran, Thomas P Loughran, Won Seog Kim, Jaehyuk Choi, Juliette Roels, Lena Boehme, Tom Putteman, Tom Taghon, Jeffrey A Barnes, P Connor Connor Johnson, Eric D Jacobsen, Steven A Greenberg, David M Weinstock, Salvia Jain
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Morgane Cheminant, René-Olivier Casasnovas, Loic Ysebaert, Gandhi Laurent Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc P E André, Norma C Gutiérrez, María Jesus Peñarrubia, Philipp Bernhard Staber, Judith Trotman, Andreas Huettmann, Vittorio Stefoni, Alessandra Tucci, Patrick Fogarty, Hassan Farhat, Julie Abraham, Wajed Abarah, Fatiha Belmecheri, Vincent Ribrag, Marie-Hélène Delfau-Larue, Anne-Ségolène Cottereau, Emmanuel Itti, Ju Li, Richard Delarue, Laurence L de Leval, Judith Trotman, Emmanuel Bachy
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra, Sung Rye Park, Michael Yevgeniy Tolstorukov, Sean M McCabe, Jessica Duffy, Abner Louissaint, Jani Huuhtanen, Dipabarna Bhattacharya, Mohamed El Missiry, Min Jung Koh, Foster Powers, Elizabeth A Morgan, Lei Yang, Brandy Pinckney, Matthew J Cotton, Andrew Crabbe, Jessica Beth Ziemba, Ian Brain, Tayla B Heavican-Foral, Javeed Iqbal, Ronald Nemec, Anna Baird Rider, Josie Germain Ford, Min Ji Koh, Nora Scanlan, Thomas P Loughran, Thomas P Loughran, Won Seog Kim, Jaehyuk Choi, Juliette Roels, Lena Boehme, Tom Putteman, Tom Taghon, Jeffrey A Barnes, P Connor Connor Johnson, Eric D Jacobsen, Steven A Greenberg, David M Weinstock, Salvia Jain
KLRG1 Cell Depletion As A Novel Therapeutic Strategy In Patients With Mature T-cell lymphoma Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra, Sung Rye Park, Michael Yevgeniy Tolstorukov, Sean M McCabe, Jessica Duffy, Abner Louissaint, Jani Huuhtanen, Dipabarna Bhattacharya, Mohamed El Missiry, Min Jung Koh, Foster Powers, Elizabeth A Morgan, Lei Yang, Brandy Pinckney, Matthew J Cotton, Andrew Crabbe, Jessica Beth Ziemba, Ian Brain, Tayla B Heavican-Foral, Javeed Iqbal, Ronald Nemec, Anna Baird Rider, Josie Germain Ford, Min Ji Koh, Nora Scanlan, Thomas P Loughran, Thomas P Loughran, Won Seog Kim, Jaehyuk Choi, Juliette Roels, Lena Boehme, Tom Putteman, Tom Taghon, Jeffrey A Barnes, P Connor Connor Johnson, Eric D Jacobsen, Steven A Greenberg, David M Weinstock, Salvia Jain
KLRG1 Cell Depletion As A Novel Therapeutic Strategy In Patients With Mature T-cell lymphoma Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra, Sung Rye Park, Michael Yevgeniy Tolstorukov, Sean M McCabe, Jessica Duffy, Abner Louissaint, Jani Huuhtanen, Dipabarna Bhattacharya, Mohamed El Missiry, Min Jung Koh, Foster Powers, Elizabeth A Morgan, Lei Yang, Brandy Pinckney, Matthew J Cotton, Andrew Crabbe, Jessica Beth Ziemba, Ian Brain, Tayla B Heavican-Foral, Javeed Iqbal, Ronald Nemec, Anna Baird Rider, Josie Germain Ford, Min Ji Koh, Nora Scanlan, Thomas P Loughran, Thomas P Loughran, Won Seog Kim, Jaehyuk Choi, Juliette Roels, Lena Boehme, Tom Putteman, Tom Taghon, Jeffrey A Barnes, P Connor Connor Johnson, Eric D Jacobsen, Steven A Greenberg, David M Weinstock, Salvia Jain
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra, Sung Rye Park, Michael Yevgeniy Tolstorukov, Sean M McCabe, Jessica Duffy, Abner Louissaint, Jani Huuhtanen, Dipabarna Bhattacharya, Mohamed El Missiry, Min Jung Koh, Foster Powers, Elizabeth A Morgan, Lei Yang, Brandy Pinckney, Matthew J Cotton, Andrew Crabbe, Jessica Beth Ziemba, Ian Brain, Tayla B Heavican-Foral, Javeed Iqbal, Ronald Nemec, Anna Baird Rider, Josie Germain Ford, Min Ji Koh, Nora Scanlan, Thomas P Loughran, Thomas P Loughran, Won Seog Kim, Jaehyuk Choi, Juliette Roels, Lena Boehme, Tom Putteman, Tom Taghon, Jeffrey A Barnes, P Connor Connor Johnson, Eric D Jacobsen, Steven A Greenberg, David M Weinstock, Salvia Jain
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Seok Jin Kim, Sang Eun Yoon, Won Seog Kim
Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies. Annals of laboratory medicine (2024)
Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra, Sung Rye Park, Michael Yevgeniy Tolstorukov, Sean M McCabe, Jessica Duffy, Abner Louissaint, Jani Huuhtanen, Dipabarna Bhattacharya, Mohamed El Missiry, Min Jung Koh, Foster Powers, Elizabeth A Morgan, Lei Yang, Brandy Pinckney, Matthew J Cotton, Andrew Crabbe, Jessica Beth Ziemba, Ian Brain, Tayla B Heavican-Foral, Javeed Iqbal, Ronald Nemec, Anna Baird Rider, Josie Germain Ford, Min Ji Koh, Nora Scanlan, Thomas P Loughran, Thomas P Loughran, Won Seog Kim, Jaehyuk Choi, Juliette Roels, Lena Boehme, Tom Putteman, Tom Taghon, Jeffrey A Barnes, P Connor Connor Johnson, Eric D Jacobsen, Steven A Greenberg, David M Weinstock, Salvia Jain
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra, Sung Rye Park, Michael Yevgeniy Tolstorukov, Sean M McCabe, Jessica Duffy, Abner Louissaint, Jani Huuhtanen, Dipabarna Bhattacharya, Mohamed El Missiry, Min Jung Koh, Foster Powers, Elizabeth A Morgan, Lei Yang, Brandy Pinckney, Matthew J Cotton, Andrew Crabbe, Jessica Beth Ziemba, Ian Brain, Tayla B Heavican-Foral, Javeed Iqbal, Ronald Nemec, Anna Baird Rider, Josie Germain Ford, Min Ji Koh, Nora Scanlan, Thomas P Loughran, Thomas P Loughran, Won Seog Kim, Jaehyuk Choi, Juliette Roels, Lena Boehme, Tom Putteman, Tom Taghon, Jeffrey A Barnes, P Connor Connor Johnson, Eric D Jacobsen, Steven A Greenberg, David M Weinstock, Salvia Jain
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Morgane Cheminant, René-Olivier Casasnovas, Loic Ysebaert, Gandhi Laurent Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc P E André, Norma C Gutiérrez, María Jesus Peñarrubia, Philipp Bernhard Staber, Judith Trotman, Andreas Huettmann, Vittorio Stefoni, Alessandra Tucci, Patrick Fogarty, Hassan Farhat, Julie Abraham, Wajed Abarah, Fatiha Belmecheri, Vincent Ribrag, Marie-Hélène Delfau-Larue, Anne-Ségolène Cottereau, Emmanuel Itti, Ju Li, Richard Delarue, Laurence L de Leval, Judith Trotman, Emmanuel Bachy
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Seok Jin Kim, Sang Eun Yoon, Won Seog Kim
Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies. Annals of laboratory medicine 44 (3) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Morgane Cheminant, René-Olivier Casasnovas, Loic Ysebaert, Gandhi Laurent Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc P E André, Norma C Gutiérrez, María Jesus Peñarrubia, Philipp Bernhard Staber, Judith Trotman, Andreas Huettmann, Vittorio Stefoni, Alessandra Tucci, Patrick Fogarty, Hassan Farhat, Julie Abraham, Wajed Abarah, Fatiha Belmecheri, Vincent Ribrag, Marie-Hélène Delfau-Larue, Anne-Ségolène Cottereau, Emmanuel Itti, Ju Li, Richard Delarue, Laurence L de Leval, Judith Trotman, Emmanuel Bachy
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jung Hoon Shin, Ji Yun Lee, Gyeong-Won Lee, Won Seog Kim, Yong Park, Young Rok Do, Dea Sik Kim, Ki Hwan Kim, Yoon Seok Choi, Ja Min Byun, Junshik Hong, Inho Kim, Sung Soo Yoon, Youngil Koh
Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma. British journal of haematology (2023)
Youngkyung Jeon, Sang Eun Yoon, Junhun Cho, Seok Jin Kim, Won Seog Kim
Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma. Annals of hematology (2023)
Yong-Pyo Lee, Sang Eun Yoon, Junhun Cho, Young Hyeh Ko, Hyunji Jo, Seok Jin Kim, Won Seog Kim
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma. Annals of hematology 101 (7) (2022)
Yong-Pyo Lee, Min-Sang Lee, Sang Eun Yoon, Junhun Cho, Yeong Hak Bang, Joon Ho Shim, Won Seog Kim, Seok Jin Kim
Survival Outcomes of Patients with Follicular Lymphoma after Relapse or Progression: A Single-Center Real-World Data Analysis. Journal of oncology 2022 (2022)
Sang Eun Yoon, Hyunji Jo, Eun Suk Kang, Duck Cho, Junhun Cho, Won Seog Kim, Seok Jin Kim
Role of upfront autologous stem cell transplantation in patients newly diagnosed with primary CNS lymphoma treated with R-MVP: real-world data from a retrospective single-center analysis. Bone marrow transplantation 57 (4) (2022)
Catalina Amador, Alyssa Bouska, George Wright, Dennis D Weisenburger, Andrew L Feldman, Timothy C Greiner, Waseem Lone, Tayla B Heavican-Foral, Lynette M Smith, Stefano A Pileri, Valentina Tabanelli, German Ott, Andreas Rosenwald, Kerry Joane Savage, Graham Slack, Won Seog Kim, Young-Hyeh Ko, Yuping Li, Gehong Dong, Joo Y Song, Sarah L Ondrejka, James R Cook, Carlos Barrionuevo, Soon Thye Lim, Choon-Kiat Ong, Jennifer Chapman, Giorgio Ga Inghirami, Philipp W Raess, Sharathkumar Bhagavathi, Clare Gould, Piers Blombery, Elaine S Jaffe, Stephan W Morris, Lisa M Rimsza, Julie M Vose, Louis Staudt, Wing C John Chan, Javeed Iqbal
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Sang Eun Yoon, Won Seog Kim
Promising clinical efficacy and acceptable safety profile of sequential P-GEMOX and radiotherapy for localized ENKTL. Hematological oncology 40 (3) (2022)
Emmanuel Bachy, Vincent Camus, Catherine Thieblemont, David Sibon, René-Olivier Casasnovas, Loic Ysebaert, Gandhi Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc André, Alejandro Martin Martin Garcia-Sancho, María Jesus Peñarrubia, Philipp Bernhard Staber, Judith Trotman, Andreas Huettmann, Vittorio Stefoni, Alessandro Re, Philippe Gaulard, Marie-Hélène Delfau-Larue, Laurence de Leval, Michel Meignan, Ju Li, Judith Trotman, Richard Delarue
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Yong-Pyo Lee, Sang Eun Yoon, Yuqin Song, Seok Jin Kim, Dok Hyun Yoon, Tsai-Yun Chen, Young Il Koh, Ka Won Kang, Ho Sup Lee, Kevin Tay Kuang Wei, Soon Thye Lim, Michelle Poon, Cosphiadi Irawan, Weili Zhao, Young Rok Do, Mark Hong Lee, Soo Chin Ng, Won-Sik Lee, Ye Guo, Huilai Zhang, Hye-Jin Kang, Hwan Jung Yun, Hyo Jung Kim, Daryl Tan Chen Lung, Jae-Yong Kwak, Jae Joon Han, Yeung-Chul Mun, Sung Yong Oh, Hyeok Shim, Jung Hye Kwon, Byeong Seok Sohn, Seong Kyu Park, Jae Cheol Jo, Young Hyeh Ko, Zhu Jun, Won Seog Kim
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia. International journal of hematology 114 (3) (2021)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung-Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Carol O'Hear, Huang Huang, Antonia Kwan, Chi-Chung Li, Emily C Piccione, Michael C Wei, Shen Yin, Nancy L Bartlett
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (5) (2021)
Huiqiang Huang, Jun Zhu, Ming Yao, Tae Min Kim, Dok Hyun Yoon, Seok-Goo Cho, Hyeon Seok Eom, Soon Thye Lim, Su-Peng Yeh, Yuqin Song, Yok Lam Kwong, Jin Seok Kim, Jie Jin, Yuankai Shi, HyeJin Kim, Min Qing, Tianyuan Zhou, Grace Gao, Zongqi Dong, Ming Qi, Won Seog Kim
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study. Journal of hematology & oncology 14 (1) (2021)
Hyung-Don Kim, Hyungwoo Cho, Byeong Seok Sohn, Chan-Sik Park, Jooryung Huh, Jin Sook Ryu, Sang-Wook Lee, Sang Eun Yoon, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim, Cheolwon Suh
Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified. Leukemia & lymphoma (2021)
Ga-Young Song, Dok Hyun Yoon, Cheolwon Suh, Joon-Ho Moon, Dong Won Baek, Jin Seok Kim, Gyeong-Won Lee, Jun Ho Yi, Yong Park, Ki Sun Jung, Seok Jin Kim, Deok Hwan Yang, Won Seog Kim
Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma. Bone marrow transplantation 56 (5) (2020)
Byeong-Bae Park, Won Seog Kim, Cheolwon Suh, Jung Yong Hong, Deok Hwan Yang, Won Sik Lee, Young Rok Do, Young-Il Koh, Jong-Ho Won, Min-Kyoung Kim, Jae-Cheol Jo, Shin Young Hyun, Jeong A Kim, Young-Ha Oh, Seung Sook Lee
A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial). Leukemia & lymphoma 60 (13) (2019)